⚠ Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.
AMBUJACEM - Swing Trade Analysis with AI Signals
Back to ListSwing Trade Rating: 3.1
| Stock Code | AMBUJACEM | Market Cap | 1,32,700 Cr. | Current Price | 537 ₹ | High / Low | 625 ₹ |
| Stock P/E | 37.0 | Book Value | 206 ₹ | Dividend Yield | 0.37 % | ROCE | 8.80 % |
| ROE | 8.77 % | Face Value | 2.00 ₹ | DMA 50 | 542 ₹ | DMA 200 | 556 ₹ |
| Chg in FII Hold | -0.11 % | Chg in DII Hold | 0.23 % | PAT Qtr | 227 Cr. | PAT Prev Qtr | 1,571 Cr. |
| RSI | 50.5 | MACD | -7.28 | Volume | 10,76,973 | Avg Vol 1Wk | 32,29,311 |
| Low price | 455 ₹ | High price | 625 ₹ | PEG Ratio | 1.79 | Debt to equity | 0.02 |
| 52w Index | 48.2 % | Qtr Profit Var | -87.1 % | EPS | 13.7 ₹ | Industry PE | 30.8 |
📊 AMBUJACEM shows weak-to-moderate potential for swing trading. The current price (537 ₹) is slightly below the 50 DMA (542 ₹) and 200 DMA (556 ₹), reflecting short-term weakness. RSI at 50.5 indicates neutrality, while MACD (-7.28) suggests bearish sentiment. Fundamentals are average with ROCE (8.80%) and ROE (8.77%), but the sharp quarterly profit decline (227 Cr vs 1,571 Cr, -87.1%) raises caution. Valuation is relatively high with P/E (37.0) compared to industry average (30.8).
✅ Optimal Entry Price: Around 520–530 ₹ (near support zone close to 455 ₹).
📈 Exit Strategy: If already holding, consider exiting near 560–580 ₹ (resistance around DMA levels) or set a stop-loss below 510 ₹.
Positive
- Low debt-to-equity ratio (0.02) ensures financial stability.
- EPS of 13.7 ₹ supports profitability.
- DII holdings increased (+0.23%), showing domestic institutional confidence.
- PEG ratio of 1.79 indicates fair valuation relative to growth.
Limitation
- Price trading below DMA levels signals weak short-term momentum.
- Quarterly profit dropped sharply (-87.1%), weakening sentiment.
- MACD (-7.28) indicates bearish momentum.
- FII holdings declined (-0.11%), showing reduced foreign investor interest.
- Dividend yield of 0.37% is relatively low.
Company Negative News
- Sharp decline